BioCentury
ARTICLE | Company News

Alza, Abbott deal

September 20, 1999 7:00 AM UTC

The companies said they are in discussions with the Federal Trade Commission regarding the divestiture of AZA's U.S. rights to its Viadur Duros leuprolide prior to AZA's acquisition by Abbott (see B...